Vaxxinity Inc (VAXX)
0.09
+0.04
(+80.00%)
USD |
OTCM |
Sep 19, 10:11
Vaxxinity Enterprise Value: -8.890M for Sept. 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2024 | -8.890M |
| September 17, 2024 | -3.820M |
| September 16, 2024 | -8.890M |
| September 13, 2024 | -12.69M |
| September 12, 2024 | -3.820M |
| September 11, 2024 | -12.69M |
| September 10, 2024 | -13.96M |
| September 09, 2024 | -10.16M |
| September 06, 2024 | -11.42M |
| September 05, 2024 | -15.10M |
| September 04, 2024 | -15.10M |
| September 03, 2024 | -15.10M |
| August 30, 2024 | -15.10M |
| August 29, 2024 | -15.21M |
| August 28, 2024 | -2.552M |
| August 27, 2024 | -8.890M |
| August 26, 2024 | -12.69M |
| August 23, 2024 | -12.69M |
| August 22, 2024 | -2.552M |
| August 21, 2024 | -13.96M |
| August 20, 2024 | -13.96M |
| August 19, 2024 | -12.69M |
| August 16, 2024 | -2.552M |
| August 15, 2024 | -12.60M |
| August 14, 2024 | -12.69M |
| Date | Value |
|---|---|
| August 13, 2024 | -12.69M |
| August 12, 2024 | -12.69M |
| August 09, 2024 | -12.69M |
| August 08, 2024 | -12.69M |
| August 07, 2024 | -12.69M |
| August 06, 2024 | -12.69M |
| August 05, 2024 | -11.42M |
| August 02, 2024 | -10.16M |
| August 01, 2024 | -10.41M |
| July 31, 2024 | -10.16M |
| July 30, 2024 | -8.890M |
| July 29, 2024 | -8.890M |
| July 26, 2024 | -11.42M |
| July 25, 2024 | -7.622M |
| July 24, 2024 | -2.552M |
| July 23, 2024 | -2.552M |
| July 22, 2024 | -2.552M |
| July 19, 2024 | -2.552M |
| July 18, 2024 | 10.12M |
| July 17, 2024 | 29.77M |
| July 16, 2024 | 33.82M |
| July 15, 2024 | 33.70M |
| July 12, 2024 | 29.13M |
| July 11, 2024 | 28.50M |
| July 10, 2024 | 30.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.21M
Minimum
Aug 29 2024
2.234B
Maximum
Nov 26 2021
240.82M
Average
165.39M
Median
Enterprise Value Benchmarks
| CEL-SCI Corp | 68.49M |
| AIM ImmunoTech Inc | 9.620M |
| IGC Pharma Inc | 24.03M |
| NovaBay Pharmaceuticals Inc | 2.443M |
| Protalix BioTherapeutics Inc | 55.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.39M |
| Total Expenses (Quarterly) | 11.65M |
| EPS Diluted (Quarterly) | -0.09 |
| Earnings Yield | -500.0% |
| Normalized Earnings Yield | -1117.83 |